857 reports of this reaction
4.5% of all DEXAMETHASONE SODIUM PHOSPHATE reports
#1 most reported adverse reaction
OFF LABEL USE is the #1 most commonly reported adverse reaction for DEXAMETHASONE SODIUM PHOSPHATE, manufactured by Amneal Pharmaceuticals LLC. There are 857 FDA adverse event reports linking DEXAMETHASONE SODIUM PHOSPHATE to OFF LABEL USE. This represents approximately 4.5% of all 19,106 adverse event reports for this drug.
Patients taking DEXAMETHASONE SODIUM PHOSPHATE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is moderately reported among DEXAMETHASONE SODIUM PHOSPHATE users, representing a notable but not dominant share of adverse events.
In addition to off label use, the following adverse reactions have been reported for DEXAMETHASONE SODIUM PHOSPHATE:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 857 FDA reports for DEXAMETHASONE SODIUM PHOSPHATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 4.5% of all adverse event reports for DEXAMETHASONE SODIUM PHOSPHATE, making it one of the most commonly reported side effect.
If you experience off label use while taking DEXAMETHASONE SODIUM PHOSPHATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.